Tong Shu

Statistics

Publications

Citations

340

H-Index

Active since

2017

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

Peking University

Peking University Cancer Hospital

Tong Shu is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2017–2024

Publications

MGMT-activated DUB3 stabilizes MCL1 and drives chemoresistance in ovarian cancer

Xiaowei Wu, Qingyu Luo, Pengfei Zhao et al. · Proceedings of the National Academy of Sciences · 2019 · 94 citations · Full text

Medicine, Molecular Biology, Oncology +11

JOSD1 inhibits mitochondrial apoptotic signalling to drive acquired chemoresistance in gynaecological cancer by stabilizing MCL1

Xiaowei Wu, Qingyu Luo, Pengfei Zhao et al. · Cell Death and Differentiation · 2019 · 87 citations · Full text

Medicine, Cancer Biology, Oncology +12

ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2

Qingyu Luo, Xiaowei Wu, Yiping Zhang et al. · Cancer Letters · 2018 · 58 citations

Medicine, Cancer Biology, Oncology +17

Prognostic evaluation of postoperative adjuvant therapy for operable cervical cancer: 10 years’ experience of National Cancer Center in China

Tong Shu, Dan Zhao, Bin Li et al. · Chinese Journal of Cancer Research · 2017 · 27 citations

Medicine, Gynecology, Oncology +16

Down-regulation of HECTD3 by HER2 inhibition makes serous ovarian cancer cells sensitive to platinum treatment

Tong Shu, Yi Li, Xiaowei Wu et al. · Cancer Letters · 2017 · 22 citations

Medicine, Cancer Biology, Oncology +14

1–5 of 9